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r Thomas L. Spray (Philadelphia, Pa). Although great im-
rovements in results for stage 1 Norwood procedures have been
chieved over the past decade, there continues to be a very sig-
ificant mortality with this procedure, and the cause of this early
ortality remains frustratingly obscure. Many centers have noted
igher mortality associated with certain anatomic and genetic risk
actors, such as aortic atresia, associated cardiac or noncardiac
nomalies, low birth weight, and so on, but this compelling study
dds a new and important risk group: patients with aortic atresia,
itral stenosis, and associated coronary fistulae from a small left
entricle. Although these patients represent a minority of the total
roup of patients with HLHS, they appear to be a major and,
erhaps in your series, the major source of mortality, at least in
oston.
Stimulated somewhat by this article, I went back and looked at
n experience from our own center over about a 3-year period
nding in May 2005 when we began the SVR trial randomization.
f 176 stage 1 operations in that 3-year period, our incidence of
ortic atresia/mitral stenosis was about 12%, and therefore a little
it less than what you saw in Boston in your own experience.
hen I got the comparison mortality data for all of those patients,
he overall survival was 92% in the patients without aortic atresia/
itral stenosis and 84% in those with aortic atresia/mitral stenosis.
lthough the numbers are very small, there were only 19 patients
ith aortic atresia/mitral stenosis, and that is probably not a
tatistically significant difference, or at least it leaves some cre-
ence to the finding that you have noted here.
Interestingly, though, at about a year, the overall survival rates
n the 2 groups were the same, and there was no interstage
ortality in the group with aortic atresia and mitral stenosis, which
gain is somewhat surprising.
I have several questions for the authors. First, are coronary
stulae limited to this subgroup, to the patients with aortic atresia/
itral stenosis? Do they occur if there is a small ventricular septal
efect or some other decompressing mode of the left ventricle?
pparently, they still do occur if you have mitral regurgitation, as
ou noted, which you would think would be a decompressing force
n the left ventricle.
How accurate is echocardiography in making this diagnosis?
re you looking for this in every patient? Do you ever see it in the
ther subgroups? How specific is this?
I must say that in our own center, our echocardiography folks
ccasionally mention this, but they do not seem to go to great
engths to try to look for these fistulae. I wonder, is that different
n Boston?
Dr Vida. Thank you very much for all your questions.
With regard to your first question, we did not study the pres-
nce of fistulae at the preoperative echocardiographic analysis in
ther subgroups of patient with HLHS. We reviewed a number of
athologic reports in the literature that demonstrated that the
resence of coronary fistula or left ventricle–coronary artery com-
unication was basically limited to patients with the aortic atresia/
itral stenosis variant of HLHS.
In response to your second question, we have considered the
resence of a ventricular septal defect as a possible differential
iagnosis in this group of patients because the fistulae are most
ften localized in the region of the ventricular septum. However,
uary 2008
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Ds reported in the literature, the exact nature of the flow pattern in
he fistulae is a critical element of diagnostic accuracy. The flow in
he coronary fistulae was found to be from the ventricle to the
oronary artery in systole and from the coronary artery to the
entricle in diastole, and therefore there was to-and-fro flow across
he fistula. In the case of a ventricular septal defect, you can have
nly have flow going from the left ventricle to the right ventricle,
oth in systole and diastole.
With regard to the sensitivity of echocardiography as a diag-
osis tool, we were quite surprised to find that there was 92%
35/38 patients) consensus in the diagnosis of fistulae between the
separate senior echocardiographers who blindly reviewed the
reoperative echocardiographic studies of all the patients in our
tudy. Interestingly, one can make a comparison to the diagnosis of
stulae in patients with pulmonary atresia and intact ventricular
eptum, where echocardiography is 90% accurate in patients who
re later confirmed to have coronary fistulae by means of angio-
raphic analysis. In conclusion, we think that even though we
annot analyze the number, the magnitude, and the significance of
hese fistulae, we can diagnose their presence, and this was found
o be significantly related to a worse hospital outcome.
Dr Spray. You sort of lead into my second question with that
eference. Most of the mortality was early, early after surgical
ntervention in your series, and most of the deaths seemed to be
rom complications, to some extent, of RV dysfunction. I mean,
ven the sepsis is sort of related to a prolonged hospitalization,
uggesting that intraoperative events are causative of this poor
utcome.
Because the majority of these patients can be expected to have
right coronary–dominant coronary pattern based on previous
natomic studies of this subtype of patients and because in your
wn institution patients with pulmonary atresia and intact ventric-
lar septum and right ventricle–dependent coronary circulation do
ot seem to have such early ventricular dysfunction or dysfunction
t the time of shunt procedures or Fontan operations, do you think
here are potentially other anatomic features that might not have
een assessed here? The smaller aorta might not be effective, but
hat about tricuspid regurgitation? You did not mention that as
ne of the variables. What about preoperative RV dysfunction; was
hat present? That might account for some of these differences in
utcome.
Dr Vida. As discussed, we analyzed various anatomic vari-
bles in these patients without finding any significant difference
etween those patients with and without coronary fistulae. What
e found is that 7 of the 11 patients who died or had a failed stage
procedure had RV failure, and the possible mechanism of death
n these patients was myocardial ischemia. Five of the patients had
roblems being weaned off CPB, and 3 patients required ECMO
upport in the operating room.
We are now prospectively studying all patients with a diagnosis
f HLHS and aortic atresia/mitral stenosis who had an echocar-
iographic diagnosis of coronary fistulae with angiography to
nderstand whether there are other anatomic variables that we are
issing.
We have 5 patients who have a preoperative angiographic
onfirmation of coronary fistulae: 3 were included in this study,
nd 2 were not included because they did not have a traditional l
The Journal of Thoracictage I palliation but rather underwent a hybrid stage 1 procedure.
oth are alive and were discharged home.
We also reviewed the routine cardiac angiography that is per-
ormed before the BDG procedure. Only 8 patients had a left
entriculography, and in 2 of the 3 patients with the preoperative
iagnosis of coronary fistulae, there was complete regression of
hese fistulae. Therefore this again is something that needs to be
onsidered for further study.
Dr Spray. Did you do any posts on the patients who died? If
ou did, did you find any common mechanism or common pattern
f injury? Were these ventricular dysfunctions because of ischemic
amage?
Dr Vida. There were 4 patients who had an autopsy; 2 of them
re heart specimens obtained at the time of the transplantation. The
nly remarkable thing that we have found was the presence of
tresia of the left coronary ostium with aortocoronary discontinu-
tion in 1 patient. All the blood flow to the left coronary artery was
rovided by the huge fistula between the left ventricle and the left
oronary artery. In all the other patients, we found signs of isch-
mia with infarcted myocardium.
Dr Spray. I think this study should stimulate other centers to
o back and analyze their own patient groups. I think it is hopeful
hat data from the ongoing SVR trial, which is a randomized trial
ith a much larger multi-institutional patient population, will be
ble to separate out these characteristics and support these inter-
sting findings.
Dr Christian Pizarro (Wilmington, Del). That was a great
resentation.
What was the source of pulmonary blood flow in these pa-
ients? Were they evenly distributed between Blalock–Taussig
hunts and RV-PA conduct?
Dr Vida. The source of pulmonary blood flow was an mBTS in
3 patients and an RV-PA conduit in 15 patients. Before 2004, the
ource of pulmonary blood flow was chosen according to sur-
eon’s preference, whereas since January 2004, it has been ran-
omized according to the SVR trial.
Dr Pizarro. Did you observe any difference?
Dr Vida. No, there was no difference in hospital outcome
ccording to the type of pulmonary blood flow in this group of
atients.
Dr Pizarro. Not at all?
Dr Vida. No.
Dr Pizarro. How do you explain the difference in the length of
ypass between the patients who did well and the ones who did
ot? Did you change the shunt, or did you do anything about it?
Dr Vida. As previously discussed, 5 of the 11 patients who had
bad outcome needed to go back on bypass because of hemody-
amic instability and signs of myocardial ischemia characterized
y ST-segment changes at echocardiography. In 1 patient we had
o redo the Damus–Kaye–Stansel anastomosis because we thought
he problem was residual arch obstruction with possible coronary
nvolvement, but that was not the case. Therefore we believe that
he prolonged CPB times in patients who died or had a failed stage
procedure were due to myocardial ischemia after the surgical
alliation caused by the coronary fistulae.
Dr Pizarro. I would just caution you regarding your last
onclusion. In reference to the hybrid procedure, I think there is at
east anecdotal experience to suggest that the physiology of a
and Cardiovascular Surgery ● Volume 135, Number 2 345
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Dybrid procedure is very similar to that in patients who undergo a
tage 1 Norwood procedure with a Blalock–Taussig shunt, and
herefore the problematic issue regarding coronary perfusion re-
ains. Although it is a lesser intervention, I think the physiology
s probably not as favorable.
Dr Vida. We believe that the main advantage of the hybrid
rocedure is the avoidance of the CPB and crossclamp times. The
voidance of myocardial ischemia might be a key point in explain-
ng the better outcome in certain patients in our series.
Dr Christian Brizard (Melbourne, Australia). I have 2 short
uestions.
I wonder whether you have demonstrated a difference of size in
he left ventricle and whether that would give a hint toward a left
nd right ventricle interaction in this group of patients.
Second, I understand that you have now a strategy to demon-
trate preoperatively coronary artery fistulae. If you do demon-
trate coronary fistulae, what do you do differently?
Dr Vida. With regard to your first question, one of the first
ariables we have analyzed in exploring the higher mortality in
his group of patients was the size of the left ventricle and its
nteraction with the motion of the ventricular septum. However,
e did not find any difference in size between patients with
stulae and those without fistulae. Again, there was no differ-
nce in the size of the left ventricle between those patients who
ied and those who survived the stage I palliation. In addition,
e tried to correlate the Z-score of the mitral valve with the
resence of fistulae, like comparing the Z-score of the tricuspid
alve and the presence of fistulae in patients with pulmonary a
46 The Journal of Thoracic and Cardiovascular Surgery ● Febrtresia and intact ventricular septum, but again, no relationship
as been found.
In response to your second question, we have a new policy in
ur institution to perform cardiac angiography, with LV injection
n all patients with preoperative echocardiographic diagnosis of
oronary fistulae. If the presence of fistulae is confirmed by means
f angiographic analysis, we now consider alternative management
trategies, such as the hybrid procedure and heart transplantation.
e have performed the hybrid procedure in 2 patients with these
haracteristics, and both were discharged home and are alive. The
ole of primary heart transplantation in these patients is still a
uch debated point.
Dr Emile A. Bacha (Boston, Mass). I have just a quick
ddendum to Dr Spray’s comment about what he found with the
hiladelphia patients. It is very important to point out that we
elieve that it is the fistulae per se that are the problem. If you do
ot look for the LV coronary fistulae, you might not really look at
he root of the problem. Aortic atresia/mitral stenosis alone in our
eries without fistulae was not tied with a higher mortality at all.
herefore if you have aortic atresia/mitral stenosis per se without
stulae, your survival is about the same, but if you have aortic
tresia/mitral stenosis with fistulae—and I would stress the point
hat you have to look for them—survival is worse. It is really
omething that one has to look for, either by means of echocar-
iographic analysis or by means of catheterization. Once we
tarted looking for them, it emerged as one of the risk factors,
uttressed by some of the pathology data that Vlad mentioned.
hat is a very important point not to be confused with just aortic
tresia/mitral stenosis alone.
uary 2008
